Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells
- 14 July 2000
- journal article
- Published by Elsevier in Life Sciences
- Vol. 67 (8) , 863-876
- https://doi.org/10.1016/s0024-3205(00)00680-9